Journals / Turkish Journal of Hematology / 2011 / Cilt: 28 - Sayı: 2

X’e bağlı trombositopenili iki Türk kardeşte Wiskott Aldrich sendromu mutasyonu

Wiskott-Aldrich syndrome mutation in two Turkish siblings with X-linked thrombocytopenia

Pages
139–141
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To the best of our knowledge this mutation has not been previously reported in a Turkish patient with XLT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Wiskott-Aldrich syndrome (WAS) is a clinical condition characterized by thrombocytopenia, eczema, and life-threatening infections.
📊
Key Findings & Data:Herein we report 2 siblings with chronic thrombocytopenia that were diagnosed with XLT based on a missense mutation in the WASP gene (223G>A, Val75Met).
💡
Conclusion & Impact:To the best of our knowledge this mutation has not been previously reported in a Turkish patient with XLT.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Wiskott-Aldrich syndrome (WAS) is a clinical condition characterized by thrombocytopenia, eczema, and life-threatening infections. In some cases autoimmunity-related problems and even malignancy might be seen; however, some patients have milder clinical manifestations due to mutations in the same gene family, such as in X-linked thrombocytopenia (XLT), which is generally not associated with serious symptoms of disease, except for thrombocytopenia. Herein we report 2 siblings with chronic thrombocytopenia that were diagnosed with XLT based on a missense mutation in the WASP gene (223G>A, Val75Met). To the best of our knowledge this mutation has not been previously reported in a Turkish patient with XLT.

Özet

Wiskott Aldrich Sendromu (WAS) trombositopeni, egzema ve hayatı tehdit edici enfeksiyonlar ile karakterize klinik durumdur. Bazı vakalarda otoimmünite ile ilgili problemler hatta malign hastalıklar da görülebilmektedir. Bunların yanında aynı gen ailesinden köken alan bazı mutasyonlarda daha hafif klinik seyir görülmektedir. X’e bağlı trombositopeni bunlardan biri olup genellikle trombositopeni dışındaki ciddi semptomları taşımaz. Burada kronik trombositopenisi olan iki erkek kardeş, WASP geninde bir missens mutasyona bağlı X’e bağlı trombositopeni tanısı almaları nedeniyle sunulmuştur. Bu mutasyon bildiğimiz kadarıyla X’e bağlı trombositopeni tanılı Türk hastalarda daha önce bildirilmemiştir.

🔖

Cite This Article

LEBLEBİSATAN, G., BAY, A., MİTSUİKİ, N., OHARA, O., HONMA, K., İMAİ, K., NONOYAMA, S. (2011). X’e bağlı trombositopenili iki Türk kardeşte Wiskott Aldrich sendromu mutasyonu. Turkish Journal of Hematology, Cilt: 28 - Sayı: 2, 139–141. https://ajindex.com/articles/412908

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Albert MH, Bittner TC, Nonoyama S, Notarangelo LD, Burns S, Imai K, Espanol T, Fasth A, Pellier I, Strauss G, Morio T, Gathmann B, Noordzij JG, Fillat C, Hoenig M, Nathrath M, Meindl A, Pagel P Wintergerst U, Fischer A, Thrasher AJ, Belohradsky BH, Ochs HD. X-linked throm- bocytopenia (XLT) due to WAS mutations: clinical char- acteristics, long-term outcome, and treatment options. Blood 2010;115:3231-8. [CrossRef] Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S. Clinical course of patients with WASP gene mutations. Blood 2004;103:456- 64. [CrossRef] Ochs HD, Filipovich AH, Veys P Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and labo- ratory manifestations, and treatment. Biol Blood Marrow Transplant 2009;15:84-90. [CrossRef] Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006;117:725-38. [CrossRef] Gulácsy V, Freiberger T, Shcherbina A, Pac M, Chernyshova L, Avcin T, Kondratenko I, Kostyuchenko L, Prokofjeva T, Pasic S, Bernatowska E, Kutukculer N, Rascon J, Iagaru N, Mazza C, Tóth B, Erdös M, van der Burg M, Maródi L. The J Project Study Group. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome. Mol Immunol 2011;48:788-92. [CrossRef] Rengan R, Ochs HD. Molecular biology of the Wiskott- Aldrich syndrome. Rev Immunogenet 2000;2:243-55. Thrasher AJ. New insights into the biology of Wiskott- Aldrich syndrome (WAS). Hematology Am Soc Hematol Educ Program 2009;132-8. [CrossRef] Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P Gandellini F, Stewart DM, Zhu Q, Nelson DL, Notarangelo LD, Ochs HD. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004;104:4010-9. [CrossRef] Doğu F, Ariga T, Ikincioğullari A, Bozdoğan G, Aytekin C, Metin A, Babacan E. A case of Wiskott-Aldrich syn- drome with de novo mutation at exon 4. Turk J Pediatr 2006;48:66-8. [CrossRef]